Andrew P. Riley

1.3k total citations · 1 hit paper
21 papers, 980 citations indexed

About

Andrew P. Riley is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Andrew P. Riley has authored 21 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pharmacology and 8 papers in Organic Chemistry. Recurrent topics in Andrew P. Riley's work include Alkaloids: synthesis and pharmacology (8 papers), Chemical synthesis and alkaloids (8 papers) and Receptor Mechanisms and Signaling (5 papers). Andrew P. Riley is often cited by papers focused on Alkaloids: synthesis and pharmacology (8 papers), Chemical synthesis and alkaloids (8 papers) and Receptor Mechanisms and Signaling (5 papers). Andrew P. Riley collaborates with scholars based in United States, New Zealand and Canada. Andrew P. Riley's co-authors include Alfredo García, Riley L. Svec, Michelle F. Richter, Tomohiro Shirai, Paul J. Hergenrother, Bryon Drown, Thomas E. Prisinzano, Bronwyn M. Kivell, Chad E. Groer and David A. Young and has published in prestigious journals such as Nature, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Andrew P. Riley

20 papers receiving 965 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictive compound accumulation rules yield a broad-spectrum antibiotic

2017 671 citations Michelle F. Richter, Bryon Drown et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew P. Riley United States	11	466	268	243	171	100	21	980
Ajit K. Parhi United States	21	504 1.1×	324 1.2×	337 1.4×	138 0.8×	85 0.8×	37	1.1k
Kristin Jansen Labby United States	13	497 1.1×	259 1.0×	166 0.7×	172 1.0×	77 0.8×	16	1.0k
Arthur Neuberger United States	17	689 1.5×	592 2.2×	98 0.4×	178 1.0×	70 0.7×	42	1.7k
Laura C. Miller United States	11	630 1.4×	222 0.8×	391 1.6×	55 0.3×	100 1.0×	13	1.1k
Renee A. Bouley United States	11	317 0.7×	141 0.5×	328 1.3×	90 0.5×	30 0.3×	30	752
Soumya Ramu Australia	17	308 0.7×	180 0.7×	183 0.8×	150 0.9×	78 0.8×	19	764
Karl A. Hansford Australia	19	516 1.1×	142 0.5×	395 1.6×	223 1.3×	151 1.5×	33	1.1k
M.T. Hilgers United States	15	686 1.5×	162 0.6×	136 0.6×	103 0.6×	38 0.4×	17	1.1k
Jean‐François Cavalier France	20	581 1.2×	55 0.2×	312 1.3×	171 1.0×	55 0.6×	65	1.2k
Shantanu Karkare United Kingdom	7	725 1.6×	141 0.5×	176 0.7×	76 0.4×	21 0.2×	8	979

Countries citing papers authored by Andrew P. Riley

Since Specialization

Citations

This map shows the geographic impact of Andrew P. Riley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew P. Riley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew P. Riley more than expected).

Fields of papers citing papers by Andrew P. Riley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew P. Riley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew P. Riley. The network helps show where Andrew P. Riley may publish in the future.

Co-authorship network of co-authors of Andrew P. Riley

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew P. Riley. A scholar is included among the top collaborators of Andrew P. Riley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew P. Riley. Andrew P. Riley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Chongguang, Peng Huang, Trevor Howe, et al.. (2025). Pharmacological characterization of the novel selective kappa opioid receptor agonists 10-Iodo-Akuammicine and 10-Bromo-akuammicine in mice. Neuropharmacology. 268. 110316–110316.

Gour, Abhishek, et al.. (2025). Comprehensive pharmacokinetics and ADME evaluation of Akuamma alkaloids. Journal of Chromatography B. 1263. 124713–124713. 1 indexed citations

Luo, Dan, et al.. (2024). Discovery of Potent Kappa Opioid Receptor Agonists Derived from Akuammicine. Journal of Medicinal Chemistry. 67(23). 20842–20857. 2 indexed citations

Riley, Andrew P., et al.. (2024). Derivatives of Aristoquinoline Accessed through a Ritter-like Reaction. ACS Medicinal Chemistry Letters. 16(3). 406–409. 1 indexed citations

Kulkarni, Gauri, Angela Nguyen, Alison E. Ondrus, et al.. (2024). Discovery of Antinociceptive α9α10 Nicotinic Acetylcholine Receptor Antagonists by Stable Receptor Expression. ACS Chemical Biology. 19(11). 2291–2303. 1 indexed citations

Wang, Zaijie Jim, et al.. (2023). Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of Medicinal Chemistry. 66(5). 3312–3326. 5 indexed citations

Kulkarni, Gauri, Abhishek Gour, Christian J. Peters, et al.. (2023). Synthesis of α3β4 Nicotinic Acetylcholine Receptor Modulators Derived from Aristoquinoline That Reduce Reinstatement of Cocaine-Seeking Behavior. Journal of Medicinal Chemistry. 67(1). 529–542. 2 indexed citations

Riley, Andrew P., et al.. (2022). What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders. Journal of Medicinal Chemistry. 66(1). 107–121. 10 indexed citations

Riley, Andrew P., et al.. (2022). Syntheses of Aristotelia Alkaloids: Reflections in the Chiral Pool. Synlett. 33(13). 1209–1214. 4 indexed citations

10.

Shelton, Catherine L., Kathleen M. Meneely, Trey A. Ronnebaum, et al.. (2022). Rational inhibitor design for Pseudomonas aeruginosa salicylate adenylation enzyme PchD. JBIC Journal of Biological Inorganic Chemistry. 27(6). 541–551. 10 indexed citations

11.

Santarsiero, Bernard D., et al.. (2021). Synthesis of Aristoquinoline Enantiomers and Their Evaluation at the α3β4 Nicotinic Acetylcholine Receptor. Organic Letters. 23(20). 7693–7697. 10 indexed citations

12.

Friesen, J. Brent, et al.. (2020). Isolation and Pharmacological Characterization of Six Opioidergic Picralima nitida Alkaloids. Journal of Natural Products. 84(1). 71–80. 20 indexed citations

13.

Crowley, Rachel Saylor, Andrew P. Riley, R. J. Anderson, et al.. (2020). Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Design, Synthesis, and Evaluation of Analogues with Improved Potency and G-protein Activation Bias at the μ-Opioid Receptor. ACS Chemical Neuroscience. 11(12). 1781–1790. 26 indexed citations

14.

Richter, Michelle F., Bryon Drown, Andrew P. Riley, et al.. (2017). Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature. 545(7654). 299–304. 671 indexed citations breakdown →

15.

Meneely, Kathleen M., Trey A. Ronnebaum, Andrew P. Riley, Thomas E. Prisinzano, & Audrey L. Lamb. (2016). Holo Structure and Steady State Kinetics of the Thiazolinyl Imine Reductases for Siderophore Biosynthesis. Biochemistry. 55(38). 5423–5433. 13 indexed citations

16.

Crowley, Rachel Saylor, Andrew P. Riley, Alexander M. Sherwood, et al.. (2016). Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse Liability. Journal of Medicinal Chemistry. 59(24). 11027–11038. 40 indexed citations

17.

Riley, Andrew P., Alireza Eshaghi, Romy Olsha, Vanessa Allen, & Samir N. Patel. (2015). Antibiotic susceptibility of clinical isolates of Campylobacter jejuni and Campylobacter coli in Ontario, Canada during 2011–2013. Diagnostic Microbiology and Infectious Disease. 83(3). 292–294. 16 indexed citations

18.

Riley, Andrew P., Chad E. Groer, David A. Young, et al.. (2014). Synthesis and κ-Opioid Receptor Activity of Furan-Substituted Salvinorin A Analogues. Journal of Medicinal Chemistry. 57(24). 10464–10475. 91 indexed citations

19.

Meneely, Kathleen M., Qianyi Luo, Andrew P. Riley, et al.. (2014). Expanding the results of a high throughput screen against an isochorismate-pyruvate lyase to enzymes of a similar scaffold or mechanism. Bioorganic & Medicinal Chemistry. 22(21). 5961–5969. 7 indexed citations

20.

Riley, Andrew P., Victor W. Day, Hernán A. Navarro, & Thomas E. Prisinzano. (2013). Palladium-Catalyzed Transformations of Salvinorin A, a Neoclerodane Diterpene from Salvia divinorum. Organic Letters. 15(23). 5936–5939. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact